Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus
- PMID: 23545115
- DOI: 10.1016/j.endonu.2012.12.007
Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus
Abstract
Prevention of high incidence of cardiovascular disease in diabetes is one of the challenges of endocrinology. Validation of new biomarkers that may contribute to a better assessment of cardiovascular risk and help implement treatment strategies is one of the promising approaches in research on prevention and reduction of cardiovascular risk. Modification of low density lipoprotein (LDL) is a key element in development of atherosclerotic lesions. Several pathophysiological characteristics of diabetes are crucial for the LDL of these patients to have higher modification rates as compared to the healthy population. Diabetic dyslipidemia, hyperglycemia, and oxidative stress synergistically promote the occurrence of lipoperoxidation, glycosylation and glycoxidation processes, which will generate modified lipoproteins that stimulate development of atherosclerosis. This article reviews the role of different types of modified LDL in development of atherosclerosis in diabetes, as well as the possibility of using its quantification in cardiovascular risk prediction.
Keywords: Arteriosclerosis; Atherosclerosis; Biomarcadores; Biomarkers; Cardiovascular risk; Diabetes mellitus; Lipoproteínas modificadas; Modified lipoproteins; Riesgo cardiovascular.
Copyright © 2012 SEEN. Published by Elsevier Espana. All rights reserved.
Similar articles
-
Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome.Front Biosci (Landmark Ed). 2018 Jan 1;23(7):1220-1240. doi: 10.2741/4640. Front Biosci (Landmark Ed). 2018. PMID: 28930596 Review.
-
[Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].Rinsho Byori. 2010 Jun;58(6):622-30. Rinsho Byori. 2010. PMID: 20662275 Review. Japanese.
-
[Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].Medicina (B Aires). 2000;60(5 Pt 1):645-56. Medicina (B Aires). 2000. PMID: 11188909 Review. Spanish.
-
Atherosclerotic risk factors in cardiovascular disease.J Reprod Med. 1986 Sep;31(9 Suppl):906-12. J Reprod Med. 1986. PMID: 3772910
-
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.J Cardiol. 2014 Jan;63(1):60-8. doi: 10.1016/j.jjcc.2013.06.018. Epub 2013 Sep 7. J Cardiol. 2014. PMID: 24016623
Cited by
-
Comet assay as an indirect measure of systemic oxidative stress.J Vis Exp. 2015 May 22;(99):e52763. doi: 10.3791/52763. J Vis Exp. 2015. PMID: 26065491 Free PMC article.
-
Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk.J Clin Med. 2021 Apr 20;10(8):1798. doi: 10.3390/jcm10081798. J Clin Med. 2021. PMID: 33924265 Free PMC article. Review.
-
Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Int J Mol Sci. 2014 Jul 21;15(7):12807-41. doi: 10.3390/ijms150712807. Int J Mol Sci. 2014. PMID: 25050779 Free PMC article. Review.
-
Study on the levels of glycosylated lipoprotein in patients with coronary artery atherosclerosis.J Clin Lab Anal. 2019 Jan;33(1):e22650. doi: 10.1002/jcla.22650. Epub 2018 Aug 12. J Clin Lab Anal. 2019. PMID: 30101436 Free PMC article.
-
The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus.Metabolites. 2021 Nov 28;11(12):807. doi: 10.3390/metabo11120807. Metabolites. 2021. PMID: 34940565 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
